Bernstein Liebhard LLP Investigates Claims on Behalf of Those Who Invested in Nektar Therapeutics
admin2015-03-18T21:17:11+00:00March 18, 2015 Bernstein Liebhard LLP is investigating whether Nektar Therapeutics (“Nektar” or the “Company”) (NASDAQ: NKTR) issued materially false and misleading statements to investors in [...]